ADAR and monocytic leukemia: To investigate the role of human RLRs in the induction of type I IFN caused by the absence of ADAR1, we first knocked out RIG‐I, MDA5, or LGP2 in the human monocytic leukemia cell line THP‐1 using CRISPR/Cas9‐mediated genome engineering.